EUVIMEDEUVIMED entdecken
Crossref

Using laboratory hemostasis tests for predicting interoperative bleeding after surgical treatment of tumors of the musculoskeletal system

Anna N. Balandina, Nadezhda A. Podoplelova, Anna A. Chankina, Sergey A. Zouzov, Elmar R. Musaev

Medical academic journal · 27.06.2026 · 26 (2) · 5-14

DOI: 10.17816/maj687647 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical academic journal, online erschienen am 27.06.2026. Verfasst von Anna N. Balandina und 4 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Surgical resection of musculoskeletal tumors is frequently associated with significant blood loss; however, data on optimal strategies to assess and mitigate intraoperative bleeding remain limited. To date, no systematic investigation has been conducted to identify predictors of blood loss among hemostatic laboratory parameters in these patients. AIM: To evaluate the prognostic value of standard and global hemostasis assays for stratifying the risk of intraoperative blood loss in patients with musculoskeletal tumors, as well as to characterize the diagnostic sensitivity and specificity of the identified laboratory markers of massive bleeding. METHODS: A total of 120 patients (58 males, 62 females; aged 18–89 years) undergoing musculoskeletal tumor surgery with high blood loss (≥1000 ml) or low blood loss (≤200 ml) were included. Blood samples were collected on the day of surgery before the procedure. Clotting times, fibrinogen and D-dimer levels, and thrombodynamics global assay parameters were analyzed. RESULTS: The preoperative hemostasis profile was characterized by elevated fibrinogen and D-dimer levels and increased clotting activity on thrombodynamics, whereas activated partial thromboplastin time, Quick prothrombin time, and thrombin time were prolonged or normal. Predictors of high intraoperative blood loss included: Prothrombin activity 94.9% (ROC-AUC = 0.730), fibrinogen 3.69 g/L (0.647), D-dimer 0.8 mg/L (0.714), Tlag 1.65 min (0.611), initial clot growth rate Vi 53.85 µm/min (0.672), clot growth rate V 39.25 µm/min (0.679), D 27.53 × 10³ AU (0.743), and absence of spontaneous clotting on thrombodynamics preoperatively. CONCLUSION: Preoperative prothrombin, fibrinogen, and D-dimer levels, as well as thrombodynamics parameters, can serve as markers of high blood loss during surgical resection of musculoskeletal tumors.

Zitieren

APA

Balandina, A. N., Podoplelova, N. A., Chankina, A. A., Zouzov, S. A., & Musaev, E. R. (2026). Using laboratory hemostasis tests for predicting interoperative bleeding after surgical treatment of tumors of the musculoskeletal system. Medical academic journal, 26(2), 5-14. https://doi.org/10.17816/maj687647

Vancouver

Balandina AN, Podoplelova NA, Chankina AA, Zouzov SA, Musaev ER. Using laboratory hemostasis tests for predicting interoperative bleeding after surgical treatment of tumors of the musculoskeletal system. Medical academic journal. 2026;26(2):5-14. doi:10.17816/maj687647

BibTeX
@article{Balandina2026,
  author = {Balandina, Anna N. and Podoplelova, Nadezhda A. and Chankina, Anna A. and Zouzov, Sergey A. and Musaev, Elmar R.},
  title = {Using laboratory hemostasis tests for predicting interoperative bleeding after surgical treatment of tumors of the musculoskeletal system},
  journal = {Medical academic journal},
  year = {2026},
  volume = {26},
  number = {2},
  pages = {5--14},
  doi = {10.17816/maj687647}
}
Kostenlos starten →